Quantcast

Latest Oxycodone Stories

2014-05-21 08:28:20

- Rapid and effective relief for all racehorses in study MELBOURNE, Australia, May 21, 2014 /PRNewswire/ -- A Phosphagenics Limited (ASX:POH, OTCQX: PPGNY) study using its TPM(®)/Oxycodone topical patch to manage shin soreness pain for thoroughbred racehorses found recovery from pain in all horses within 1-2 days. The study was conducted on six thoroughbreds, between two and three years of age, exhibiting cannon (shin) bone soreness arising from injuries in either one or two...

2014-05-13 08:31:21

--Webcast and conference call today at 8:30 a.m. EDT-- WAYNE, Penn., May 13, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the three months ended March 31, 2014. First quarter highlights include: -- Initiated pivotal bioequivalence studies of Egalet-001; -- Received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Egalet-001, an abuse-deterrent,...

2014-05-08 12:29:29

RICHMOND, Va., May 8, 2014 /PRNewswire-iReach/ -- Dr. Peter Coleman, the National Medical Director of The Coleman Institute, was voted top addiction medicine specialist in Richmond Magazine's 2014 "Top Doctors" survey. Photo - http://photos.prnewswire.com/prnh/20140508/85672 The Richmond Magazine survey asks local physicians to recommend doctors in 82 categories, ranging from neurology, to pediatrics, and to addiction. Dr. Coleman received the most amount of votes in the Addiction...

2014-05-05 20:28:14

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Drugs of Abuse Testing Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/drugs_abuse_testing_markets.htmlThis TriMark Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as drugs of abuse testing. In the current medical diagnostics market, drugs of abuse testing offers promise for significant growth and innovation. Examined in this...

2014-04-30 12:30:02

Patent Protection for KP511 Extends KemPharm's Intellectual Property Estate for Leading Franchise of Abuse-Deterrent Opioid Medications CORALVILLE, Iowa, April 30, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application titled, "Benzoic...

2014-04-29 08:35:55

WAYNE, Pa., April 29, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its first quarter financial results will be released on Tuesday, May 13, 2014. Following the announcement, Egalet's management will host a live conference call and webcast at 8:30 a.m. Eastern Time to review the company's financial and operating results and provide a general business update. http://photos.prnewswire.com/prnvar/20140219/NY67493LOGO Interested parties may...

2014-04-22 20:22:20

SYDNEY and BEDMINSTER, N.J., April 22, 2014 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee has voted to recommend against approval of Moxduo, an immediate release Dual Opioid(®) for the treatment of moderate to severe acute pain. The Advisory Committee found the Company did not provide sufficient evidence to warrant approval of Moxduo at this...

2014-04-16 12:30:32

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/lzqfh9/drugs_of_abuse) has announced the addition of the "Drugs of Abuse Testing Markets" [http://www.researchandmarkets.com/research/lzqfh9/drugs_of_abuse ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the specific segment of the in vitro diagnostics (IVD) market known as drugs of abuse testing....

2014-04-15 08:30:49

Continued dialogue needed to make a tangible difference OTTAWA, April 15, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, reaffirmed her commitment to tackle the growing problem of prescription drug abuse head on. The Government of Canada will continue to work with groups like the Canadian Centre on Substance Abuse, different levels of government, doctors, pharmacists, First Nations representatives, law enforcement and addictions specialists to help combat...

2014-04-11 08:24:52

SAN DIEGO, April 11, 2014 /PRNewswire/ -- Rampant misinformation about Zohydro(TM) ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals. These inaccurate and misleading statements are often made without proper context, and are intended to be sensational, to create fear, or to generate headlines. In many instances, these statements are not supported by scientific facts or medical evidence. Let's get the facts straight Zohydro ER is the first and...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.